Related Articles
Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin
Monthly intravesical bacillus Calmette-Guérin maintenance therapy for non-muscle-invasive bladder cancer: 10-year experience in a single institute
Improved antitumor efficacy of neutrophils stimulated by bacillus Calmette‑Guérin
Production of IL-5, a classical T(H)2 cytokine, following bacillus Calmette guerin immunotherapy of bladder cancer
Recombinant hIFN-α2b-BCG inhibits tumor growth in a mouse model of bladder cancer